Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Jun 16, 2025; 17(6): 104539
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104539
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104539
Table 2 Diagnostic modalities including computed tomography scan and endoscopic ultrasonography details
Variable | Frequency (No.) | Percentage (%) |
Total | 14 | 100.0 |
CT scan status | ||
Yes | 13 | 92.9 |
No | 1 | 7.1 |
CT scan successfully identifies lesion | ||
Yes | 13 | 100.0 |
EGD | ||
Yes | 1 | 7.1 |
No | 13 | 92.9 |
Indication for EUS based on CT and EGD findings | ||
Pancreatic mass | 6 | 42.9 |
Pancreatic cyst | 1 | 7.1 |
Pancreatic tail lesion and ductal dilation | 1 | 7.1 |
Porta hepatis mass | 2 | 14.3 |
Paraduodenal lesion | 1 | 7.1 |
Liver lesion | 1 | 7.1 |
Mediastinal lymphadenopathy | 1 | 7.1 |
Extrinsic mass compressing pyloric area | 1 | 7.1 |
EUS diagnosis | ||
EUS guided FNB | 14 | 100.0 |
Complications | 0 | 0.0 |
EUS procedure’s setting | ||
Endoscopy suite | 13 | 92.9 |
In-patient | 1 | 7.1 |
- Citation: Ayesha S, Karim MM, Shahid AH, Rehman AU, Uddin Z, Abid S. Diagnostic role of endoscopic ultrasonography in defining the clinical features and histopathological spectrum of gastroenteropancreatic neuroendocrine tumors. World J Gastrointest Endosc 2025; 17(6): 104539
- URL: https://www.wjgnet.com/1948-5190/full/v17/i6/104539.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i6.104539